كندا - الإنجليزية - Health Canada

panda pharmaceuticals inc. - bosentan (bosentan monohydrate) - tablet - 125mg - bosentan (bosentan monohydrate) 125mg - vasodilating agents

كندا - الإنجليزية - Health Canada

accel pharma inc - bosentan (bosentan monohydrate) - tablet - 125mg - bosentan (bosentan monohydrate) 125mg - vasodilating agents

كندا - الإنجليزية - Health Canada

taro pharmaceuticals inc - bosentan (bosentan monohydrate) - tablet - 62.5mg - bosentan (bosentan monohydrate) 62.5mg - vasodilating agents

كندا - الإنجليزية - Health Canada

taro pharmaceuticals inc - bosentan (bosentan monohydrate) - tablet - 125mg - bosentan (bosentan monohydrate) 125mg - vasodilating agents

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - bosentan monohydrate, quantity: 129.08 mg (equivalent: bosentan, qty 125 mg) - tablet, film coated - excipient ingredients: magnesium stearate; ethylcellulose; purified talc; pregelatinised maize starch; iron oxide red; iron oxide yellow; glyceryl behenate; triacetin; maize starch; titanium dioxide; sodium starch glycollate; hypromellose; povidone - tracleer is indicated for the treatment of: idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, pulmonary arterial hypertension associated with scleroderma or pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger's physiology in patients with who functional class ii, iii or iv symptoms.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - bosentan monohydrate, quantity: 64.54 mg (equivalent: bosentan, qty 62.5 mg) - tablet, film coated - excipient ingredients: maize starch; iron oxide yellow; glyceryl behenate; triacetin; iron oxide red; purified talc; magnesium stearate; titanium dioxide; hypromellose; povidone; sodium starch glycollate; ethylcellulose; pregelatinised maize starch - tracleer is indicated for the treatment of: idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, pulmonary arterial hypertension associated with scleroderma or pulmonary arterial hypertension associated with congenital systemic to pulmonary shunts including eisenmenger's physiology in patients with who functional class ii, iii or iv symptoms.

الفلبين - الإنجليزية - FDA (Food And Drug Administration)

actelion pharmaceuticals ltd.; importer: johnson & johnson (philippines), inc. - selexipag - film-coated tablet - 200 mcg

الفلبين - الإنجليزية - FDA (Food And Drug Administration)

actelion pharmaceuticals ltd.; importer: johnson & johnson (philippines), inc. - selexipag - film-coated tablet - 400 mcg

الفلبين - الإنجليزية - FDA (Food And Drug Administration)

actelion pharmaceuticals ltd.; importer: johnson & johnson (philippines), inc. - selexipag - film-coated tablet - 600 mcg

الفلبين - الإنجليزية - FDA (Food And Drug Administration)

actelion pharmaceuticals ltd.; importer: johnson & johnson (philippines), inc. - selexipag - film-coated tablet - 800 mcg